Last updated on April 2019

A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer


Brief description of study

The purpose of this study is to determine the safety and efficacy of nab-paclitaxel and gemcitabine with or without olaratumab in the treatment of first-line metastatic pancreatic cancer.

Clinical Study Identifier: NCT03086369

Find a site near you

Start Over

Tennessee Oncology PLLC

Nashville, TN United States
  Connect »

University of Utah School of Medicine

Salt Lake City, UT United States
  Connect »

Highlands Oncology Group

Fayetteville, AR United States
  Connect »

St Jude Medical Center

Fullerton, CA United States
  Connect »

UCLA Medical Center

Los Angeles, CA United States
  Connect »

Florida Cancer Specialists

Fort Myers, FL United States
  Connect »

Cancer Center of Kansas

Wichita, KS United States
  Connect »

Research Medical Center

Kansas City, MO United States
  Connect »

Monter Cancer Center

Lake Success, NY United States
  Connect »

NYU Clinical Cancer Center

New York, NY United States
  Connect »

Thomas Jefferson University

Philadelphia, PA United States
  Connect »

Sanford Research/USD

Sioux Falls, SD United States
  Connect »

UPMC Hillman Cancer Center

Pittsburgh, PA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.